Jennison Associates
SNDX icon

Jennison Associates’s Syndax Pharmaceuticals SNDX Stock Holding History

Jennison Associates’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-51,334
Closed -$1.05M – 637
2024
Q2 		$1.05M Buy
51,334
+1,164
+2% +$24.4K ﹤0.01% 484
2024
Q1 		$1.19M Sell
50,170
-610
-1% -$13.6K ﹤0.01% 485
2023
Q4 		$1.1M Sell
50,780
-2,296,893
-98% -$35.3M ﹤0.01% 484
2023
Q3 		$34.1M Sell
2,347,673
-174,243
-7% -$3.3M 0.03% 238
2023
Q2 		$52.8M Buy
2,521,916
+105,462
+4% +$2.2M 0.04% 185
2023
Q1 		$51M Buy
2,416,454
+114,208
+5% +$2.84M 0.05% 180
2022
Q4 		$58.6M Buy
2,302,246
+652,451
+40% +$15.2M 0.06% 167
2022
Q3 		$39.6M Buy
+1,649,795
New +$37M 0.04% 208
2018
Q1 		– Sell
-531,028
Closed -$4.65M – 697
2017
Q4 		$4.65M Sell
531,028
-420,870
-44% -$4.16M ﹤0.01% 501
2017
Q3 		$11.1M Sell
951,898
-1,964
-0.2% -$24.1K 0.01% 472
2017
Q2 		$13.3M Buy
+953,862
New +$10.9M 0.01% 453
2017
Q1 		– Sell
-93,783
Closed -$672K – 776
2016
Q4 		$672K Sell
93,783
-289,993
-76% -$3.18M ﹤0.01% 648
2016
Q3 		$5.82M Sell
383,776
-153,769
-29% -$2.02M 0.01% 505
2016
Q2 		$5.25M Buy
537,545
+76,653
+17% +$1.05M 0.01% 499
2016
Q1 		$5.98M Buy
+460,892
New +$5.79M 0.01% 482

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates's SNDX Position: Q3 2024 in Review

Jennison Associates sold out of Syndax Pharmaceuticals (SNDX) in Q3 2024, closing a stake of 51,334 shares — an estimated $1.05M sold.

Jennison Associates first reported a position in SNDX in Q1 2016 and held it in 15 quarters. The position peaked at $58.6M in Q4 2022. 210 funds tracked by Wall St. Rank hold SNDX as of Q3 2024.

  • Jennison Associates reported no remaining Syndax Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Jennison Associates sold 51,334 Syndax Pharmaceuticals shares in Q3 2024, an estimated $1.05M.
  • Jennison Associates first reported a position in Syndax Pharmaceuticals in Q1 2016 and held it in 15 quarters.
  • Jennison Associates's Syndax Pharmaceuticals position peaked at $58.6M in Q4 2022.
  • 210 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2024.

Based on Jennison Associates's 13F filing for Q3 2024, filed 8 Nov 2024.